Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study

Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study

Arthur Roberts,1–3 Alec Sithole,4 Marcos Sedghi,5 Charles A Walker,6,7 Theresa M Quinn,8 1Indiana Craniofacial Center, 2Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Indianapolis, IN, USA; 3Department of Anesthesia, Critical Care, and Pain Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roberts A, Sithole A, Sedghi M, Walker CA, Quinn TM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
The peri-auricular percutaneous implantation of the Neuro-Stim System (NSS©) family of devices EAD©
MFS©
BRIDGE© (Innovative Health Solutions
Versailles IN) is a non-opiate
neuromodulation analgesic used for acute and chronic pain conditions. It is cleared as a minimal risk procedure by multiple governmental and institutional facilities. This retrospective report of findings will help quantify the incidence of clinically observed bleeding
localized dermatitis and infections at the implantation sites of the electrode/needle arrays
dermatitis at the site of the generator
and patient syncope. A total of 1
207 devices
each producing up to 16 percutaneous punctures
for a total of 19
312 punctures were monitored for adverse effects
based on retrospective chart audits conducted at 6 clinical facilities over a one-year period.
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/3a767777e98a4c1a9c6046983d71db8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares